Adjuvant endocrine therapy for premenopausal breast cancer patients should be individualized

Oncologists should take an individualized approach when making decisions about adjuvant endocrine therapies for premenopausal hormone receptor–positive, HER2-negative early breast cancer, suggests an...
Source: Clinical Endocrinology News - Category: Endocrinology Source Type: news